TrialPanorama/TrialPanorama-database huggingface dataset:
Study 26223768 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 26224101 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 26227009 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26227009 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26227106 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26227106 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26227106 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 26230182 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26230660 — Safety Biomarker (SAF): miR-16
Study 26230660 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 26230660 — Predictive Biomarker (PRD): miR-106a
Genes: MIR106A
Study 26230660 — Safety Biomarker (SAF): miR-200c
Genes: MIR200C
Study 26237773 — Surrogate Endpoint (SUR): Blood pressure
Study 26238730 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 26238974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26239690 — Predictive Biomarker (PRD): PDP1 mRNA
Genes: PDP1; PDP; PPM2C
Study 26241763 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 26242184 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 26242713 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 26243260 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26243260 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26243260 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 26243260 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 26244396 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26244832 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26245279 — Surrogate Endpoint (SUR): Blood pressure
Study 26245948 — Predictive Biomarker (PRD): CCDC88A mRNA
Genes: CCDC88A; APE; GRDN; KIAA1212
Study 26246845 — Predictive Biomarker (PRD): DGAT1 mRNA
Genes: DGAT1; AGRP1; DGAT
Study 26246845 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26250067 — Safety Biomarker (SAF): DRD2
Study 26251214 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 26252914 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26259955 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 26259955 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 26260306 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 26261061 — Predictive Biomarker (PRD): AGXT mRNA
Genes: AGXT; AGT1; SPAT
Study 26261061 — Predictive Biomarker (PRD): ERCC2 mRNA
Genes: ERCC2; XPD; XPDC
Study 26261061 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study 26261061 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study 26261061 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study 26261061 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 26261061 — Predictive Biomarker (PRD): XRCC3 mRNA
Genes: XRCC3
Study 26261849 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26261849 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 26263403 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26263832 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 26263832 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 26264378 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 26265479 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 26265479 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 26265479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26265479 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26265479 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 26265479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26265699 — Predictive Biomarker (PRD): GRIN3A mRNA
Genes: GRIN3A; KIAA1973
Study 26266842 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study 26268313 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26268313 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 26268514 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26268514 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 26268844 — Surrogate Endpoint (SUR): Blood pressure
Study 26269367 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study 26269367 — Safety Biomarker (SAF): MTHFR
Study 26269367 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 26272656 — Predictive Biomarker (PRD): PITX2 mRNA
Genes: PITX2; ARP1; RGS; RIEG; RIEG1
Study 26272656 — Predictive Biomarker (PRD): ZFHX3 mRNA
Genes: ZFHX3; ATBF1; C16orf47
Study 26272656 — Predictive Biomarker (PRD): KCNN3 mRNA
Genes: KCNN3; K3
Study 26273092 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26273092 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26274928 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 26274928 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 26275293 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 26275293 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 26275293 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 26275293 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 26275293 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26275293 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 26275293 — Predictive Biomarker (PRD): HMGA2 mRNA
Genes: HMGA2; HMGIC
Study 26275293 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26275293 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26275521 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 26275521 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 26275521 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 26280447 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 26280447 — Surrogate Endpoint (SUR): Blood pressure
Study 26283632 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 26284168 — Predictive Biomarker (PRD): ACTN3 mRNA
Genes: ACTN3
Study 26285132 — Predictive Biomarker (PRD): GTF2I mRNA
Genes: GTF2I; BAP135; WBSCR6
Study 26285741 — Surrogate Endpoint (SUR): Blood pressure
Study 26286255 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 26286255 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 26290644 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study 26290644 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 26291023 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 26291296 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26291753 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 26292583 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study 26293568 — Surrogate Endpoint (SUR): Blood pressure
Study 26293760 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26296092 — Surrogate Endpoint (SUR): Hematologic response
Study 26296295 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26296295 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26296473 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study 26297144 — Surrogate Endpoint (SUR): Blood pressure
Study 26297176 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26297222 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26297222 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26300945 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 26300986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26300986 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26302738 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 26304872 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 26304872 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26304872 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26306290 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 26306290 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 26308285 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 26308596 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26308942 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study 26308942 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 26310837 — Surrogate Endpoint (SUR): Blood pressure
Study 26311446 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 26312070 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 26312070 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26312070 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26312070 — Surrogate Endpoint (SUR): Blood pressure
Study 26312852 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26312852 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 26312852 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study 26313170 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26313445 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 26314740 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26315712 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26315949 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 26315949 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26315967 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26316385 — Surrogate Endpoint (SUR): Serum creatinine
Study 26316523 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26317543 — Predictive Biomarker (PRD): TTL mRNA
Genes: TTL
Study 26318254 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26318254 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study 26318254 — Predictive Biomarker (PRD): MAP3K7 mRNA
Genes: MAP3K7; TAK1
Study 26318254 — Predictive Biomarker (PRD): TRADD mRNA
Genes: TRADD
Study 26318254 — Predictive Biomarker (PRD): TANK mRNA
Genes: TANK; ITRAF; TRAF2
Study 26321472 — Safety Biomarker (SAF): CDA
Genes: CDD
Study 26323022 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 26323022 — Surrogate Endpoint (SUR): Bone mineral density
Study 26324363 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 26324363 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 26324363 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 26324363 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 26330458 — Predictive Biomarker (PRD): EDNRB mRNA
Genes: EDNRB; ETRB
Study 26330458 — Predictive Biomarker (PRD): BCL2A1 mRNA
Genes: BCL2A1; BCL2L5; BFL1; GRS; HBPA1
Study 26330458 — Predictive Biomarker (PRD): PARP3 mRNA
Genes: PARP3; ADPRT3; ADPRTL3
Study 26330458 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study 26332545 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 26332545 — Predictive Biomarker (PRD): ASXL1 mRNA
Genes: ASXL1; KIAA0978
Study 26332545 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study 26332546 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 26332546 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study 26332546 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 26333343 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 26333343 — Surrogate Endpoint (SUR): Serum creatinine
Study 26333941 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26334219 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study 26334761 — Surrogate Endpoint (SUR): Blood pressure
Study 26335027 — Predictive Biomarker (PRD): NUCB2 mRNA
Genes: NUCB2; NEFA
Study 26335066 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 26336199 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26336608 — Predictive Biomarker (PRD): CD300LG mRNA
Genes: CD300LG; CLM9; TREM4; UNQ422/PRO846
Study 26336930 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 26336930 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 26337035 — Surrogate Endpoint (SUR): Blood pressure
Study 26337145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26337346 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 26337354 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 26337493 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 26338094 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 26338888 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26339493 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 26343039 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 26343110 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 26343949 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26344676 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 26344676 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 26344676 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 26346136 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 26348869 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 26349821 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 26351026 — Surrogate Endpoint (SUR): Blood pressure
Study 26351289 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26351323 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study 26351323 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26351323 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 26351392 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26352814 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 26352815 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 26354756 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 26354756 — Predictive Biomarker (PRD): PIK3R2 mRNA
Genes: PIK3R2
Study 26354756 — Predictive Biomarker (PRD): miR-145
Genes: MIR145
Study 26354756 — Monitoring Biomarker (MOI): miR-145-5p
Genes: MIR145
Study 26354756 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 26355551 — Predictive Biomarker (PRD): ASNS mRNA
Genes: ASNS; TS11
Study 26355551 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 26355708 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26355708 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 26358172 — Surrogate Endpoint (SUR): Bone mineral density
Study 26358358 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26358358 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26360334 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 26362881 — Predictive Biomarker (PRD): CEACAM6 mRNA
Genes: CEACAM6; NCA
Study 26362881 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 26363834 — Predictive Biomarker (PRD): KLK3 mRNA
Genes: KLK3; APS
Study 26364690 — Surrogate Endpoint (SUR): Blood pressure
Study 26366430 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 26366430 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26367236 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 26369751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 26370838 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 26373629 — Surrogate Endpoint (SUR): Blood pressure
Study 26373629 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26373629 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26375439 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26375670 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26376348 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26376436 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26376436 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26376436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26376436 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 26376436 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26376459 — Surrogate Endpoint (SUR): Serum asparaginase
Study 26377379 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study 26377379 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 26377379 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 26377597 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 26379163 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26379437 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 26380150 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 26382589 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26383952 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 26384163 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 26384789 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26385385 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 26385402 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 26386044 — Predictive Biomarker (PRD): KIAA0586 mRNA
Genes: KIAA0586; TALPID3
Study 26388950 — Surrogate Endpoint (SUR): Blood pressure
Study 26388950 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26388950 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26389849 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 26390038 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 26390038 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study 26390837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26392035 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 26392102 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 26392102 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26392102 — Predictive Biomarker (PRD): Microsatellite instability
Study 26392763 — Predictive Biomarker (PRD): LRIT1 mRNA
Genes: LRIT1; LRRC21; PAL
Study 26392763 — Surrogate Endpoint (SUR): Blood pressure
Study 26392838 — Surrogate Endpoint (SUR): Blood pressure
Study 26396157 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26398290 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 26398503 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 26400297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 26401256 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 26402159 — Predictive Biomarker (PRD): LEF1 mRNA
Genes: LEF1
Study 26402159 — Safety Biomarker (SAF): Inhibin beta B chain
Genes: INHBB
Study 26404501 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 26405576 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26405584 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26407163 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26407163 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26407255 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 26409873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26409873 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26413873 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26413903 — Surrogate Endpoint (SUR): Bone mineral density
Study 26415600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 26416513 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26416896 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 26416897 — Predictive Biomarker (PRD): TBK1 mRNA
Genes: TBK1; NAK